Cellular Orthopedics Blog
Stem Cell Claims versus Outcomes Data
It is now over four years since I began the most comprehensive outcomes clinical trial ever undertaken in which Bone Marrow Concentrate was used to reduce pain, improve function, increase activities and alter the progression of osteoarthritis in a knee joint. At the...
Osteoarthritis, back to basics
Also known as degenerative joint disease, osteoarthritis is the most common joint disorder, and continues to be the leading cause of impaired quality of life in the United Sates. While OA is defined as the progressive loss of cartilage structure and function; that...
On Cartilage Regeneration
Last week, my associate attended a continued medical education course held in a venue near the Wisconsin-Illinois border; a site frequently used by the Stem Cell Institute of America to host amniotic fluid marketing seminars. My colleague overheard a conversation...
Weight loss can slow down knee joint degeneration
NON-INTERVENTIONAL MEANS OF MANAGING KNEE ARTHRITIS A PUBLIC SERVICE ANNOUNCEMENT PUBLIC RELEASE: 2-MAY-2017 Weight loss can slow down knee joint degeneration CREDIT: RADIOLOGICAL SOCIETY OF NORTH AMERICA OAK BROOK, Ill. - Overweight and obese people who lost a...
STEM CELLS
My clinical practice mission is to use autologous concentrated marrow-derived mononuclear cells for the care and treatment of a joint afflicted by degenerative arthritis so as to assist a patient in postponing, perhaps avoiding a joint replacement. I then follow the...
Decision Making in Interventional Orthopedics
I have purposely used the terms interventional orthopedics and cellular orthopedics when referring to regenerative medicine to remind my reader that I am an orthopedic surgeon. Later in life, I graduated into my present role as a clinician seeking to assist a patient...
All Regenerative Physicians are Not the Same
I am an orthopedic surgeon. The new focus for the arthritic joint is restoration and not replacement. Almost five years ago, I joined that emerging initiative after a 37-year professional career of having replaced joints. One of the recent problems emerging in this...
In Cellular Orthopedics, New Doesn’t Necessarily Mean Better
As most readers of this Blog already know, for more than 37 years, I was a reconstructive joint replacement surgeon at a major Chicago medical center, where I served as the director of the joint replacement program. I retired as emeritus professor seven years ago;...
The tale of two people with arthritic knees
It came to pass over the last several weeks that I had contact with two separate patients; one in my office and one by e-mail inquiry. Both individuals had, prior to treatment, roughly the same levels of arthritic impairment. Both with grade three arthritic knees,...
An exclusive interview with Interventional Orthopedic Surgical pioneer Mitchell Sheinkop, MD, (continued)
Blog: Dr. Sheinkop , let’s pick up where we ended at the last interview. You were going to tell us about the hip labrum? Sheinkop: Recently, there has been an increased frequency of diagnosis pertaining to an acetabular labral tear when a patient presents to a...
Don’t be fooled by bogus stem cell claims
When it comes to cellular orthopedics, for me, it is a matter of honor and self-interest. If you aren't aware of the bogus stem cell claims or "false news", read the LA Times article that appeared last week...
An exclusive Interview With Interventional Orthopedic Surgeon, Mitchell Sheinkop, MD
Blog: “Please explain Interventional Orthopedics?” Dr Sheinkop: “Five years ago, after 37 years of performing hip and knee replacements at a major medical center in Chicago, where I served as director of the Joint Replacement program, I exchanged the scalpel for a...